Year: 2016
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Identification of aggressive endometrioid endometrial carcinomas (EECs) and non-endometrioid carcinomas (NEECs) is essential to improve outcome. L1 cell adhesion molecule (L1CAM) expression is a strong prognostic marker in stage I EECs, but less is known about L1CAM expression in advanced-stage EECs and NEECs. This study analyses L1CAM expression in a clinically representative cohort of endometrial carcinomas. METHODS: The expression of L1CAM was immunohistochemically determined in 1199 endometrial carcinomas, treated at one of the European Network for Individualized Treatment of Endometrial Cancer (ENITEC) centres. Staining was considered positive when >10% of the tumour cells expressed L1CAM. The association between L1CAM expression and several clincopathological characteristics and disease outcome was calculated. RESULTS: In all, L1CAM was expressed in 10% of the 935 stage I EECs, 18% of the 160 advanced stage EECs, and 75% of the 104 NEECs. The expression of L1CAM was associated with advanced stage, nodal involvement, high tumour grade, non-endometrioid histology, lymphovascular space invasion, and distant recurrences in all cases, and with reduced survival in the EECs, but not in the NEECs. CONCLUSIONS: The expression of L1CAM is a strong predictor of poor outcome in EECs, but not NEECs. It is strongly associated with non-endometrioid histology and distant spread, and could improve the postoperative selection of high-risk endometrial carcinomas. The value of L1CAM expression in the preoperative selection of high-risk endometrial carcinomas should be studied.
Source: British Journal of Cancer
DOI: 10.1038/bjc.2016.235
Authors: Louis JM van der Putten, Nicole CM Visser, Koen van de Vijver, Maria Santacana, Peter Bronsert, Johan Bulten, Marc Hirschfeld, Eva Colas, Antonio Gil-Moreno, Angel Garcia, Gemma Mancebo, Fransesc Alameda, Jone Trovik, Reidun K Kopperud, Jutta Huvila, Stefanie Schrauwen, Martin Koskas, Francine Walker, Vit Weinberger, Lubos Minar, Eva Jandakova, Marc PLM Snijders, Saskia van den Berg-van Erp, Xavier Matias-Guiu, Helga B Salvesen, Frederic Amant, Leon FAG Massuger, Johanna MA Pijnenborg
Institutions: Radboud University Medical Center, The Netherlands Cancer Institute, Universitat de Lleida, Hospital Universitari Arnau de Vilanova, Instituto de Investigación Biomédica de Lleida, University Medical Center Freiburg, German Cancer Research Center, Deutsches Konsortium für Translationale Krebsforschung, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Hospital Del Mar, Haukeland University Hospital, University of Bergen, University of Turku, Universitair Ziekenhuis Leuven, Hôpital Bichat-Claude-Bernard, Masaryk University, Canisius-Wilhelmina Ziekenhuis, Elisabeth-TweeSteden Ziekenhuis
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
Funders: Deutsches Krebsforschungszentrum, Radboud Universiteit, Universitetet i Bergen, Turun Yliopisto, Radboud Universitair Medisch Centrum, Universitat de Lleida, Haukeland Universitetssjukehus, Fundació Institut de Recerca Hospital Universitari Vall d’Hebron, Deutschen Konsortium für Translationale Krebsforschung
Awards: G2188863825, G4477223514
OpenAlex ID: W2511088334
